ASTRAZENECA SIGNS $5B AI RESEARCH DEAL WITH CHINA'S CSPC

Summary from the TLDR AI newsletter

AstraZeneca will pay $110 million upfront for CSPC to use AI-driven research to discover small molecule therapies, including an oral treatment for immunological diseases.